Eric Valeur

3.4k total citations · 1 hit paper
17 papers, 2.7k citations indexed

About

Eric Valeur is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Eric Valeur has authored 17 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Organic Chemistry and 3 papers in Computational Theory and Mathematics. Recurrent topics in Eric Valeur's work include Chemical Synthesis and Analysis (9 papers), Click Chemistry and Applications (5 papers) and Computational Drug Discovery Methods (3 papers). Eric Valeur is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Click Chemistry and Applications (5 papers) and Computational Drug Discovery Methods (3 papers). Eric Valeur collaborates with scholars based in Sweden, Germany and United Kingdom. Eric Valeur's co-authors include Mark Bradley, R. Gopalakrishnan, Alleyn T. Plowright, Malin Lemurell, Laurent Knerr, Herbert Waldmann, Tom N. Grossmann, William J. Drury, Stéphanie M. Guéret and Hélène Adihou and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Angewandte Chemie International Edition.

In The Last Decade

Eric Valeur

17 papers receiving 2.7k citations

Hit Papers

Amide bond formation: beyond the myth of coupling reagents 2008 2026 2014 2020 2008 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Valeur Sweden 14 2.1k 1.8k 467 140 139 17 2.7k
Vijaya R. Pattabiraman Switzerland 18 2.0k 1.0× 2.0k 1.1× 503 1.1× 83 0.6× 222 1.6× 30 2.6k
Munetaka Kunishima Japan 26 1.1k 0.5× 2.2k 1.2× 259 0.6× 182 1.3× 92 0.7× 131 2.8k
Christian Montalbetti United Kingdom 10 1.2k 0.6× 1.3k 0.7× 307 0.7× 101 0.7× 88 0.6× 26 1.9k
Mathieu Pucheault France 26 1.1k 0.5× 1.4k 0.8× 339 0.7× 267 1.9× 274 2.0× 73 2.5k
Kenneth G. Carson United States 13 989 0.5× 1.2k 0.6× 454 1.0× 90 0.6× 172 1.2× 19 2.0k
Dennis Gillingham Switzerland 24 992 0.5× 2.0k 1.1× 287 0.6× 99 0.7× 128 0.9× 55 2.5k
Bertrand Carboni France 32 1.0k 0.5× 3.3k 1.8× 440 0.9× 90 0.6× 94 0.7× 165 3.7k
Takashi Ikawa Japan 30 567 0.3× 2.3k 1.3× 556 1.2× 177 1.3× 109 0.8× 94 3.2k
Ming‐Sheng Xie China 38 1.1k 0.5× 3.4k 1.9× 649 1.4× 149 1.1× 166 1.2× 149 4.4k
Hongjun Ren China 31 841 0.4× 2.7k 1.5× 239 0.5× 334 2.4× 119 0.9× 93 3.4k

Countries citing papers authored by Eric Valeur

Since Specialization
Citations

This map shows the geographic impact of Eric Valeur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Valeur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Valeur more than expected).

Fields of papers citing papers by Eric Valeur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Valeur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Valeur. The network helps show where Eric Valeur may publish in the future.

Co-authorship network of co-authors of Eric Valeur

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Valeur. A scholar is included among the top collaborators of Eric Valeur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Valeur. Eric Valeur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Guéret, Stéphanie M., Rodrigo J. Carbajo, Marco Potowski, et al.. (2020). Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments. Journal of the American Chemical Society. 142(10). 4904–4915. 35 indexed citations
2.
Noisier, Anaïs F. M., Magnus J. Johansson, Laurent Knerr, et al.. (2019). Late‐Stage Functionalization of Histidine in Unprotected Peptides. Angewandte Chemie International Edition. 58(52). 19096–19102. 55 indexed citations
3.
Noisier, Anaïs F. M., Magnus J. Johansson, Laurent Knerr, et al.. (2019). Late‐Stage Functionalization of Histidine in Unprotected Peptides. Angewandte Chemie. 131(52). 19272–19278. 29 indexed citations
4.
Valeur, Eric, Frank Narjes, Christian Ottmann, & Alleyn T. Plowright. (2019). Emerging modes-of-action in drug discovery. MedChemComm. 10(9). 1550–1568. 18 indexed citations
5.
Ämmälä, Carina, William J. Drury, Laurent Knerr, et al.. (2018). Targeted delivery of antisense oligonucleotides to pancreatic β-cells. Science Advances. 4(10). eaat3386–eaat3386. 127 indexed citations
6.
Valeur, Eric & Patrick Jimonet. (2018). New Modalities, Technologies, and Partnerships in Probe and Lead Generation: Enabling a Mode-of-Action Centric Paradigm. Journal of Medicinal Chemistry. 61(20). 9004–9029. 24 indexed citations
7.
Fridén‐Saxin, Maria, Göran Dahl, Paul Wan, et al.. (2018). Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligase. Chemical Science. 9(27). 5957–5966. 19 indexed citations
8.
Davis, A. M., Alleyn T. Plowright, & Eric Valeur. (2017). Directing evolution: the next revolution in drug discovery?. Nature Reviews Drug Discovery. 16(10). 681–698. 63 indexed citations
9.
Valeur, Eric, Stéphanie M. Guéret, Hélène Adihou, et al.. (2017). Neue Modalitäten für schwierige Zielstrukturen in der Wirkstoffentwicklung. Angewandte Chemie. 129(35). 10428–10459. 37 indexed citations
10.
Valeur, Eric, Stéphanie M. Guéret, Hélène Adihou, et al.. (2017). New Modalities for Challenging Targets in Drug Discovery. Angewandte Chemie International Edition. 56(35). 10294–10323. 290 indexed citations
11.
Valeur, Eric, et al.. (2016). Targeted delivery for regenerative medicines: an untapped opportunity for drug conjugates. Drug Discovery Today. 22(6). 841–847. 12 indexed citations
12.
Gopalakrishnan, R., Andrey I. Frolov, Laurent Knerr, William J. Drury, & Eric Valeur. (2016). Therapeutic Potential of Foldamers: From Chemical Biology Tools To Drug Candidates?. Journal of Medicinal Chemistry. 59(21). 9599–9621. 134 indexed citations
13.
Roche, Didier, et al.. (2010). PS-SNAP, a practical polymer-supported nitrosation reagent in organic synthesis. Tetrahedron Letters. 51(17). 2277–2280. 11 indexed citations
14.
Valeur, Eric & Mark Bradley. (2008). Amide bond formation: beyond the myth of coupling reagents. Chemical Society Reviews. 38(2). 606–631. 1833 indexed citations breakdown →
15.
Valeur, Eric & Didier Roche. (2008). Efficient, mild, parallel and purification-free synthesis of aryl ethers via the Mitsunobu reaction. Tetrahedron Letters. 49(26). 4182–4185. 10 indexed citations
16.
Valeur, Eric & Mark Bradley. (2007). PS-IIDQ: a supported coupling reagent for efficient and general amide bond formation. Tetrahedron. 63(36). 8855–8871. 19 indexed citations
17.
Valeur, Eric & Mark Bradley. (2005). PS-IIDQ: an efficient polymer-supported amide coupling reagent. Chemical Communications. 1164–1164. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026